Safeguard Scientifics, Inc. · OTC:SFES
Safeguard Scientifics — Investor Presentation (August 2020)
29 slides from Safeguard Scientifics's investor presentation, Aug 27, 2020
Slide 1: Investor Presentation August 2020
& SAFEGUARD y 4 Investor Presentation August 2020
Slide 2: Forward-looking Statements
Forward-looking Statements Statements made in this presentation include forward-looking statements, and those statements are subject to risks and uncertainties, which include, but are not limited to, Safeguard’s ability to make good decisions about the monetization of our ownership interests for max
Slide 3: Safeguard Scientifics, Inc.
Safeguard Scientifics, Inc. Safeguard has an attractive portfolio of tech-enabled healthcare, digital media and other companies — total cost of ownership interests approximating $236 million + Encouraged by portfolio companies’ liquidity/performance subsequent to COVID-19 impact + Three companies in
Slide 4: Companies by Revenue Stage
Companies by Revenue Stage y / Al No pre-revenue Proven business Maturing companies models portfolio Indicates Company that me Quuilibrium flashtalking“,, achievednew stage during Q2 a2. Zipnosis Revenue: $50M+ AKTANA Lumesis syapse QuanticMind Sas - Revenue: $20M - $50 va Trice Medical €3WebLinc G)
Slide 5: Aggregate Portfolio Revenue
Aggregate Portfolio Revenue TIM through 3/31/2020 The 5-year CAGR of the Healthcare portfolio is 54% ions) Healthcare Companies Digital Media Companies 3/31/2016 3/31/2017 3/31/2018 3/31/2019 3/31/2020 Certainamourtsin 2018 ar Actual Actual Actual Actual Actual have also been adjusted to ref wm Digi
Slide 6: Portfolio Considerations
Portfolio Considerations = Optimizing value-maximization and time to exit SFE Market Cap < Fair Market Value < Projected Future Exit Values * Carrying value does not equal Fair Market Value due to equity method accounting * Fair Market Values driven by recent financings, company performance and publ
Slide 7: Financial Matters
Financial Matters = No Debt & $13.6 n of cash and cash equivalents at June 30, 2020 = $1 per share special dividend paid to shareholders in December 2019 = Continuing to reduce costs to operate: Expected to be at the low end, or below, guidance range of $5.6 to $6.0 million * Corporate expenses down
Slide 8: Key Financial Measures
Key Financial Measures June 30, 2020 December 31, 2019 December 31, 2018 Cash, equivalents and marketable securities $13,632 $25,053 $46,158 Total Borrowings Zero Zero $65,114 Net Cash Position Positive Positive Negative # of Ownership Interests 15 15 24 General and administrative expenses $5,560 $9
Slide 9: Safeguard Scientifics, Inc.
Safeguard Scientifics, Inc. Safeguard has an attractive portfolio of tech-enabled healthcare, digital media and other companies — total cost of ownership interests approximating $236 million + Encouraged by portfolio companies’ liquidity/performance subsequent to COVID-19 impact + Three companies in
Slide 10: Appendix
& SAFEGUARD y 4 Appendix
Slide 11: Ownership Interests
Ownership Interests eae ieee stage category | Acauition | rimary | Value * (in millions) stan, Inet fev. $20M~peatheare ois WKS os $7 Chatch olan wighTrecion _oigtaledia 2ots oe 32 13 Flashtalking Rev. $SOM+ Digital Media 2018 13.4% 125 aae Meditat, n nev $s0My ipa 2009 13% : 155 Progns ett, ne Bev.
Slide 12: Condensed Consolidated Balance Sheets
Condensed Consolidated Balance Sheets Assets Cash, cash equivalents, restricted cash Other current assets Total current assets (Ownership interests in and advances Other assets Total Assets Li jabilities and Equity Other current liabilities Total current liabilities Lease liability-non-current Other
Slide 13: Income Statement
Income Statement Three Months Ended ‘six Months Ended June 30, June 30, 2020 2019 2020 2019 ‘Operating expenses $2,028 $2,603 $5)560 $ 5/860 ‘Operating loss (2,028) (2,603) (5,560) (5,660) Otherincome (loss), net (2,658) 3118 (6,225) 1,233 Interest, net 52 (4,919) 157 (6581) Equity income (loss), ne
Slide 14: Aktana—Company Overview
Aktana—Company Overview COMPANY OVERVIEW (Life Sciences / Medtech) Headquarters: SanFrancisco,CA 2 z SUMMARY cEO: David Ehrlich Origin: Tmeane + Aktana isan Al-enabled life sciences marketing decision supportsolution Capital: s1.7M that helps sales and marketing teams to optimize go-to-market strate
Slide 15: Clutch—Company Overview
Clutch—Company Overview COMPANY OVERVIEW Market Segment: Customer Rewards and Loyalty Headquarters: ‘Ambler, PA cEO: Ned Moore + A leading wholistic solution toa fragmented industry, Clutch offers, customer relationship management and a mobile commerce platform that unifies gifting, loyalty and shop
Slide 16: Flashtalking—Company Overview
Flashtalking—Company Overview cd mane copeiens: {putter abaaswen ona ananis flashtalking“,, Headquarters: New York, NY SUMMARY January 2012 (via sale of Spongecell) EO: John Nardone + A data-driven ad management and analyticstechnology company that uses data to personalize advertising in real-time,
Slide 17: InfoBionic—Company Overview
InfoBionic—Company Overview ° COMPANY OVERVIEW “INFOBIONIC Market Segment: Patient Monitoring(Cardiac) F Headquarters: Lowell, MA SUMMARY. Go Stuart Long Origin: March 2018 + A digital health company focused on creating superior patient monitoring Capital: $22.0M solutions for chroniedisease managem
Slide 18: Lumesis—Company Overview
Lumesis—Company Overview COMPANY OVERVIEW Headquarters: Stamford, CT EO: Gregg Bienstock SUNIMARY, + Lumesis is@ financial technology company focused on providing business February 2012 efficiency and compliance solutionsviaits DIVER platformto hundreds of Clients and over 45,000 users in the munici
Slide 19: MediaMath—Company Overview
MediaMath—Company Overview COMPANY OVERVIEW Market Segment: Digital Advertising / Marketing Headquarters: New York, NY EO: Joe Zawadzki + Global ad technology company that enables advertisers to optimize their digital advertising spend across ad exchanges via an algorithmictrading platform + The Com
Slide 20: meQuilibrium—Company Overview
meQuilibrium—Company Overview Shersegeenr onto ae Satie Headquarters: Boston, MA EO: Jan Bruce > SuSE wun elem eareerinrer ei SUMMARY = faiigiosareltiteateg tere ea cre smenaes enon Origin: ‘April 2015 capital and develop engaged, agile workforces pi engaged, agi = $140M + The Company offers solutio
Slide 21: Moxe—Company Overview
Moxe—Company Overview COMPANY OVERVIEW Market Segmer Interoperability Headquarters: Madison, WI cEO: Dan Wilson + Provides a clinical data clearinghouse, creating a two-sided network facilitating the bi-directionalexchange of clinical, analytic, and administrative data between health systems and pay
Slide 22: Prognos—Company Overview
Prognos—Company Overview PLOQNOS Market Segment: Healthcare Analytics /Al Headquarters: New York, NY SUMMARY ceo: ‘Sundeep Bhan November 2011 + Prognos ageregates, harmonizes and analyzes clinical diagnosticdata for EINES EMERG life sciences, diagnostic companies, and payers, aiming to improve healt
Slide 23: QuanticMind—Company Overview
QuanticMind—Company Overview COMPANY OVERVIEW Market Segment: Digital Ad Management / Paid Search Headquarters: San Mateo, CA cEO: Chaitanya Chandrasekar + QuanticMind provides a SaaS-based, next generation Search Engine Marketing ("SEM") platform or Paid Search that develops ad management point sol
Slide 24: Sonobi—Company Overview
Sonobi—Company Overview COMPANY OVERVIEW Market Segment: Premium Programmatic Ad Technology Headquarters: Winter Park, FL ceO: Michael Connolly + Proprietary Jetstream platform enables publishersto make premium advertising inventory available on their websites and mobile platforms to brands, agencie
Slide 25: Syapse—Company Overview
Syapse—Company Overview syapse Market Segment: Precision Medicine Headquarters: San Francisco, CA SUMMARY ad Ken Tare Origin: June 2014 + Multi-sided platform creatinga data network effect in order to improve . Capital: 25.0M the way cancer and other diseases retreated S = + Health systems contribut
Slide 26: Trice—Company Overview
Trice—Company Overview COMPANY OVERVIEW Market Segmer Medical Device Headquarters: cEO: Malvern, PA Mark Foster * Pioneering disposable cameras and instruments that enable faster diagnosticsand shift of low-risk procedures tothe office and surgery center settings + Trice Medical’s FDA-approved 510(k
Slide 27: WebLinc—Company Overview
WebLinc—Company Overview ; Market Serment: OnineRetaiandeconmere €’WebLinc Headquarters: Philadelphia, PA SUMMARY ‘August 2014 cEO: Darren Hill + WebLinc has 2 product offerings: 162M * Workarea-a modern, digital commerce technology platform for 3 growing e-Commerce focused companies 40% Primary + O
Slide 28: Zipnosis—Company Overview
Zipnosis—Company Overview aA ‘ Niemen: Teoria Zipnosis Headquarters: Minneapolis, MN cEO: Jon Pearce SUMMARY) Origin: December 2015 + Zipnosispartners with health systems nationwideto providea white- a STO labeled virtual care platform, offering patients convenient access tocare while improvingelini
Slide 29: & SAFEGUARD y
& SAFEGUARD y 4 Investor Presentation August 2020
Safeguard Scientifics — Investor Presentation (August 2020) on 6ix